FSTL1 and myocardial infarction: Under hypoxic conditions (such as after myocardial infarction), the secretion of FSTL1 by human cardiac fibroblasts increases, and the low-glycosylated form of FSTL1 promotes better regenerative effects, particularly in enhancing cell proliferation (Peters et al., 2022).